{"ticker": {"uuid": "c2c178ab-de03-4c23-bb66-b1c736991af9", "symbol": "317450", "name": "MYUNGIN PHARM", "exchange": "KSC", "country": "KR", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Enterprise value to revenue forward of Myung in Pharm Co., Ltd. \u2013 KRX:317450", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPTGw0aTl0VkpPNTFwOHFmWmNPQmpGVF9ubmZnRnpMSGRydVRyR2U0aTk0WHBZaEhkWm1obWM5UmlHc0pnZ1dNSmFPNkFkdDBza3dzSFhSVUM3YWpUdUIzdGwtRXc0cEwtenpTNkNnU1JpM0tiX3NUVThKUVpSdHFsWmh1eGJOal8wcThXVHVGZTM3amFGQlhwRmVkODhvWlcwaV9LcFo4Ykp1UzQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-15T20:32:49+00:00", "published_display": "15 Jul 2026 20:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Myungin Pharm secures global IP rights to Parkinson\u2019s drug Paxroya", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE8wcXROZGJDa3F0azA0dDNSWXBzZ3ZoNmI3blZoa1pOX1c1dE9vc0VjMEFuUlZnbi1RTWE2ZGV6RF9ZMVJMRTBveW1QcHpSejVYZTVJWXBwNEJBR3ZxT2NYZi1yS0lHX2RHM0NHNXh30gFyQVVfeXFMTlBqWUZ4YkRnb3g5VWN0bXRDVDZra0xuY0c4ZWNiekZkTVlVRlBsOV9ydFZaVGJyS3VKdUJFQThuckRSS04wSFRhV2MydEJUR2pHb0dXUFZpZ0lxa295VExZVlc1Y0VuRXpiUlZfV1l3Vzln?oc=5", "source_name": "koreabiomed.com", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Myungin Pharm to debut on Kospi Oct. 1 after strong investor demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFB4VmQxVV80MmJ1bTEtY0FYQW0zUUZLMERUbzVNRjRlNDZITk1HOXFLLXpBSl9KWW1oMmladUs5MGtCWVY3WkExMVhMV2NUVUZKQ09GT19wM3ZkLTdOX3p1eXRncXA2TklzX2JZZkl30gFyQVVfeXFMTkJKUE1SZEVrZDJwLVF6V0Z4VEtsVnJFSU55bklSR3U4QTA0YkVZS282X0VrRkxmM0Y2b3ZrN3lTV3ZpQjVJazRZMkt0Y2tNRjBYdTNSdGNkT1k4Z2thMzV1Z0F3Q1BHM2c1TC0teW9OcEFR?oc=5", "source_name": "koreabiomed.com", "published_at": "2025-09-30T07:00:00+00:00", "published_display": "30 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Korea\u2019s CNS leader Myung In Pharm goes Kospi for global deals", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBoVksxOWE2S1R5OWtfZmt5b3NMbzlQa3p6M0dQX1hQRHpwOEpWOEdmb3lpNzA0UWdLaGpwWEx6TmVWaGlfTWpEM0xvTHR1RUQ0Q2Rlc3dCNXJhZGdDMGx2ZnJpdjY4UG94U0ctdF930gFyQVVfeXFMT1I4TV9wVm1QSDBqRmZ2WFB5QXZXOU5VQVRQamJXbzQ1NXQzN2IxWUJRXzVVWFZEd2lKNlJtblJYOTBYbnRyVnBPZEtQRDU4MmNnNDFpT0tGN3ZDRnkwdE1rV0NLdTlwM3M1bUNCdGd0Nnln?oc=5", "source_name": "koreabiomed.com", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Enterprise value to revenue forward of Myung in Pharm Co., Ltd. \u2013 KRX:317450", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPTGw0aTl0VkpPNTFwOHFmWmNPQmpGVF9ubmZnRnpMSGRydVRyR2U0aTk0WHBZaEhkWm1obWM5UmlHc0pnZ1dNSmFPNkFkdDBza3dzSFhSVUM3YWpUdUIzdGwtRXc0cEwtenpTNkNnU1JpM0tiX3NUVThKUVpSdHFsWmh1eGJOal8wcThXVHVGZTM3amFGQlhwRmVkODhvWlcwaV9LcFo4Ykp1UzQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-15T20:32:49+00:00", "published_display": "15 Jul 2026 20:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Myungin Pharm secures global IP rights to Parkinson\u2019s drug Paxroya", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE8wcXROZGJDa3F0azA0dDNSWXBzZ3ZoNmI3blZoa1pOX1c1dE9vc0VjMEFuUlZnbi1RTWE2ZGV6RF9ZMVJMRTBveW1QcHpSejVYZTVJWXBwNEJBR3ZxT2NYZi1yS0lHX2RHM0NHNXh30gFyQVVfeXFMTlBqWUZ4YkRnb3g5VWN0bXRDVDZra0xuY0c4ZWNiekZkTVlVRlBsOV9ydFZaVGJyS3VKdUJFQThuckRSS04wSFRhV2MydEJUR2pHb0dXUFZpZ0lxa295VExZVlc1Y0VuRXpiUlZfV1l3Vzln?oc=5", "source_name": "koreabiomed.com", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Myungin Pharm to debut on Kospi Oct. 1 after strong investor demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFB4VmQxVV80MmJ1bTEtY0FYQW0zUUZLMERUbzVNRjRlNDZITk1HOXFLLXpBSl9KWW1oMmladUs5MGtCWVY3WkExMVhMV2NUVUZKQ09GT19wM3ZkLTdOX3p1eXRncXA2TklzX2JZZkl30gFyQVVfeXFMTkJKUE1SZEVrZDJwLVF6V0Z4VEtsVnJFSU55bklSR3U4QTA0YkVZS282X0VrRkxmM0Y2b3ZrN3lTV3ZpQjVJazRZMkt0Y2tNRjBYdTNSdGNkT1k4Z2thMzV1Z0F3Q1BHM2c1TC0teW9OcEFR?oc=5", "source_name": "koreabiomed.com", "published_at": "2025-09-30T07:00:00+00:00", "published_display": "30 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Korea\u2019s CNS leader Myung In Pharm goes Kospi for global deals", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBoVksxOWE2S1R5OWtfZmt5b3NMbzlQa3p6M0dQX1hQRHpwOEpWOEdmb3lpNzA0UWdLaGpwWEx6TmVWaGlfTWpEM0xvTHR1RUQ0Q2Rlc3dCNXJhZGdDMGx2ZnJpdjY4UG94U0ctdF930gFyQVVfeXFMT1I4TV9wVm1QSDBqRmZ2WFB5QXZXOU5VQVRQamJXbzQ1NXQzN2IxWUJRXzVVWFZEd2lKNlJtblJYOTBYbnRyVnBPZEtQRDU4MmNnNDFpT0tGN3ZDRnkwdE1rV0NLdTlwM3M1bUNCdGd0Nnln?oc=5", "source_name": "koreabiomed.com", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 58, "total_relevant": 4, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 3, "score": 53, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 62, "events": [{"event": "general", "label": "Market update", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 43250.0, "latest_week": "2026-07-10", "one_week_move": 1.3, "four_week_move": -0.2, "twelve_week_move": -25.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.893183, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -30.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 27.7856, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.3% over one week, -0.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "koreabiomed.com", "count": 3}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 2}, {"label": "Earnings", "count": 1}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "62/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.3% over one week, -0.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Enterprise value to revenue forward of Myung in Pharm Co., Ltd. \u2013 KRX:317450"}], "updated_at": "2026-07-17T19:18:45.000441+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}